The Joshua Arbesman lab studies genetic mechanisms that place patients at high risk for melanoma development.
The Shideng Bao lab studies glioma stem cell signaling pathways in malignant brain tumors, including glioblastoma.
The J. Mark Brown lab studies the relationship between diet, microbe, host metabolism and chronic cardiometabolic disease.
The Abhishek Chakraborty lab studies oxygen loss and processes oxygen-deprived cancer cells employ for survival.
Dr. Lai (Linda) Chan’s lab studies oncogenic signaling and metabolic reprogramming to understand how they influence cancer development and progression.
The Shuyang Chen lab has primary research interests in the environmental and genetic factors contributing to melanoma development.
The Seth Corey lab studies bone marrow failure, myelodysplastic syndromes and myeloid malignancies.
The Candece Gladson lab investigates blocking angiogenesis and key molecules that promote survival in malignant glioma tumors.
The Zihua Gong lab studies molecular mechanisms underlying DNA repair pathway choice in breast and ovarian cancers.
The Khaled Hassan lab is studying lung cancer development and progression as well as mechanisms of resistance to its treatment.
The Hannelore Heemers lab explores drug targets for novel, prostate cancer-selective forms of androgen deprivation therapy.
The Jae Jung lab studies virus-induced cancers and the mechanisms of and treatments for pathogens that cause human disease.
The Ruth Keri Lab studies breast cancer, focusing on molecularly understanding mammary morphogenesis and carcinogenesis.
The Lang lab investigates breast cancer, studying liquid biopsies, tumor biology and inflammatory breast cancer.
The Jeongwu Lee lab studies glioblastoma, focusing on cancer progression and treatment resistance.
The Brian Rubin lab studies the pathogenesis of bone and soft tissue cancers, collectively known as sarcomas.
The George Stark lab studies the complex cell signaling mechanisms underlying innate immunity and cancer.
The Jennifer Yu lab studies glioblastoma and mechanisms underlying stem cell maintenance and therapeutic resistance.
The Jianjun Zhao lab investigates deregulated coding and noncoding genes in the initiation of multiple myeloma.